Hj. Agteresch et al., Effects of ATP infusion on glucose turnover and gluconeogenesis in patients with advanced non-small-cell lung cancer, CLIN SCI, 98(6), 2000, pp. 689-695
Cancer cachexia is associated with elevated lipolysis, proteolysis and gluc
oneogenesis. ATP infusion has been found to significantly inhibit loss of b
ody weight, fat mass and fat-free mass in patients with advanced lung cance
r. The present study was aimed at exploring the effects of ATP on whole-bod
y glucose turnover, alanine turnover and gluconeogenesis from alanine. Twel
ve patients with advanced non-small-cell lung cancer (NSCLC) were studied I
week before and during 22-24 h of continuous ATP infusion. After an overni
ght fast, turnover rates of glucose and alanine, and gluconeogenesis from a
lanine, were determined using primed constant infusions of [6,6-H-2(2)]gluc
ose and [3-C-13]alanine. Thirteen NSCLC patients and eleven healthy subject
s were studied as control groups without ATP infusion. During high-dose ATP
infusion (75 mu g.min(-1).kg(-1)), glucose turnover was 0.62+/-0.07 mmol.h
(-1).kg(-1), compared with 0.44+/-0.13 mmol.h(-1).kg(-1) at baseline (P = 0
.04). For gluconeogenesis a similar, but non-significant, trend was observe
d [baseline, 0.30+/-0.16 mmol.h(-1).kg(-1); during ATP, 0.37+/-0.13 mmol.h(
-1).kg(-1) (P = 0.08)]. At lower ATP doses (37-50 mu g.min(-1).kg(-1)) thes
e effects were not detected. The relative increase in glucose turnover duri
ng ATP infusion compared with baseline showed a significant correlation wit
h the ATP dose (r = 0.58, P = 0.02). No change in alanine turnover was obse
rved at any ATP dose. The results of this study indicate an increase in glu
cose turnover during high-dose ATP infusion compared with baseline levels.
During high-dose AIP infusion, glucose turnover was similar to that during
low-dose ATP infusion and to that in control NSCLC patients. Between ATP in
fusions, however, glucose turnover in patients treated with high-dose ATP w
as significantly lower than that in the low-dose and control NSCLC patients
(P = 0.04 and P = 0.03 respectively), and similar to that in healthy subje
cts. This would suggest that repeated high-dose ATP infusions may inhibit g
lucose turnover between infusion periods.